AjaxDNA
AjaxDNA is a Valencia-based biotech startup developing an AI-driven personalised medicine platform that builds molecular maps of a patient's disease from biopsy data, combining genetics, proteomics and transcriptomics with bioinformatics and molecular modelling to identify the best existing drug or design new therapeutic candidates. Its offering pairs a software layer (Biological Intelligence) for disease mapping and drug prioritisation with a tabletop 'Lab On A Cell' device that automates and miniaturises preclinical testing and toxicology assays. Founded in 2024 by biotechnologist Alejandro Atienza, the company is in clinical validation and has been backed by the Lanzadera accelerator, with recognition including the CaixaBank EmprendeXXI 2025 Disruptive Innovation award and BIOVAL's 2024 young biotech talent award.
Founders
Global models
In the same niche 50 others
Most funded firstSee all 51 in Diagnostics & precision medicine testing →
Investors 1
Open 1 in the directory as list →
Funding rounds
News 6
Open as list →| Published | Article |
|---|---|
| 2026-05-28 |
Alejandro Atienza (AjaxDNA): “No hay dos pacientes iguales y los tratamientos tampoco deberían serlo” ↗
CatalunyaPress
2026-05-28 |
| 2026-04-23 |
Ajax DNA, la startup que pone a prueba un modelo para diseñar fármacos con datos de cada paciente ↗
ENTER.CO
2026-04-23 |
| 2025-09-09 |
Los VII Premios Ingenia Startup ya tienen ganadores: Ajax-DNA, Groditech y Uraphex ↗
Sweet Press
2025-09-09 |
| 2025-06-01 |
Tres proyectos valencianos de base tecnológica se alzan con el reconocimiento nacional en los Premios EmprendeXXI ↗
Extradigital
2025-06-01 |
| 2025-05-04 |
Un laboratorio en miniatura y una patente de Ajax DNA creará fármacos más rápido y baratos ↗
Castellón Plaza
2025-05-04 |
| 2024-10-17 |
Amparo Tolosa y Alejandro Atienza, entre los premiados en la 7ª edición de la Nit Biotec ↗
Valencia Plaza
2024-10-17 |